---------------------------------------------------------------
 详细处方信息以本药内容附件PDF文件（201081119193617.pdf）的“原文Priscribing Information”为准
---------------------------------------------------------------
部分中文AMLOPRES-Z处方资料（仅供参考）

    Amlodipine Besylate甲磺酸氨氯地平属于钙离子阻滞剂抗高血压药，能够直接检验血管平滑肌，降低心脏的后负荷，缓解心绞痛。临床上用于原发性高血压，稳定性及变异性心绞痛。

    Losartan Potassium氯沙坦钾是一种用于治疗原发性高血压的药品，适用于联合用药治疗的患者。属于血管紧张素II受体拮抗剂 (Angiotensin II Antagonists)。可同其他抗高血压药物一起使用，本品可与或不与食物同时服用。临床试验发现本品耐受性良好：不良反应轻微且短暂，一般不需终止治疗。应用本品总的不良反应发生率与安慰剂类似。

    氯沙坦钾与氨氯地平联合用药能有效降低血压，缩小脉压差，降低血尿酸浓度，改善肾功能。

US Brand Name：AMLOPRES-Z

Generic Name：Amlodipine + losartan

Other Brand Name：AMLOPRES-Z, Losar-A

Manufacturer：Cipla Limited

COMPOSITION：
AMLOPRES-Z
Each tablet contains:
Amlodipine Besylate equivalent to Amlodipine 5 mg and Losartan Potassium 50 mg.
 
INDICATIONS： 
AMLOPRES-Z is indicated for the treatment of mild to moderate hypertension. It is also indicated in hypertension not responding to monotherapy with calcium antagonists or angiotensin II receptor antagonists. It may also be substituted for the titrated doses of the individual components.
  
DOSAGE AND ADMINISTRATION：
The usual initial dosage is one tablet daily. If blood pressure control is inadequate after a week or two, the dose may be increased to two tablets daily. The dosage, however, should be individualized.
 
CONTRAINDICATIONS：
The combination is contraindicated in patients who are hypersensitive to any component of this product.

---------------------------------------------------------------
 详细处方信息以本药内容附件PDF文件（201081119193617.pdf）的“原文Priscribing Information”为准
---------------------------------------------------------------

2010年8月12日更新